REFERENCES
- Albouaini K, Mudawi J, Pyatt J, Wright D. Implantable cardioverter defibrillator: What a hospital practitioner needs to know. Eur J Intern Med. 2009;20(6):591–597.
- Klug D, Balde M, Pavin D, . Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: Results of a large prospective study. Circulation. 2007;116(12):1349–1355.
- Howie AJ, Ferreira MA, Adu D. Prognostic value of simple measurement of chronic damage in renal biopsy specimens. Nephrol Dial Transplant. 2001;16(6):1163–1169.
- Majumdar A, Chowdhary S, Ferreira MAS, . Renal pathological findings in infective endocarditis. Nephrol Dial Transplant. 2000;15(11):1782–1787.
- Raoult D, Casalta JP, Richet H, . Contribution of systematic serological testing in diagnosis of infective endocarditis. J Clin Microbiol. 2005;43(10):5238–5242.
- Eisenberger U, Fakhouri F, Vanhille P, . ANCA-negative pauci-immune renal vasculitis: Histology and outcome. Nephrol Dial Transplant. 2005;20:1392–1399.
- Chen M, Feng Y, Wang S-X, . Antineutrophil cytoplasmic autoantibody-negative pauci-immune crescentic glomerulonephritis. J Am Soc Nephrol. 2007;18:599–605.
- Kain R, Exner M, Brandes R, . Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis. Nat Med. 2008;14(10):1088–1096.
- Agarwal A, Clements J, Sedmak DD, . Subacute bacterial endocarditis masquerading as type III essential mixed cryoglobulinemia. J Am Soc Nephrol. 1997;8(12):1971–1976.
- Arber N, Pras E, Copperman Y, . Pacemaker endocarditis: Report of 44 cases and review of the literature. Medicine. 1994;73:299–305.
- , Task Force on the Prevention, Diagnosis and Treatment of Infective Endocarditis of the European Society of Cardiology; European Society of Clinical Microbiology and Infectious Diseases; International Society of Chemotherapy for Infection and CancerHabib G, Hoen B, . Guidelines on the prevention, diagnosis and treatment of infective endocarditis (new version 2009): The Task Force on the Prevention, Diagnosis and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Eur Heart J. 2009;30(19):2369–2413.
- Rundström H, Kennergren C, Andersson R, Alestig K, Hogevik H. Pacemaker endocarditis during 18 years in Göteborg. Scand J Infect Dis. 2004;36(9):674–679.
- Sohail MR, Uslan DZ, Khan AH, . Infective endocarditis complicating permanent pacemaker and implantable cardioverter-defibrillator infection. Mayo Clin Proc. 2008;83(1):46–53.
- Chua JD, Wilkoff BL, Lee I, . Diagnosis and management of infections involving implantable electrophysiological cardiac devices. Ann Intern Med. 2000;133:604–608.
- Al Soub H, Al Maslamani M, Al Khuwaiter J, El Deeb Y, Abu Khattab M. Myocardial abscess and bacteremia complicating Mycobacterium fortuitum pacemaker infection: Case report and review of the literature. Pediatr Infect Dis J. 2009;28(11):1032–1034.
- Hemmersbach-Miller M, Cárdenes-Santana MA, Conde-Martel A, Bolaños-Guerra JA, Campos-Herrero MI. Cardiac device infections due to Mycobacterium fortuitum. Can J Infect Dis Med Microbiol. 2005;16(3):183–185.
- Griffith DE, Aksamit T, Brown-Elliott BA, . An official ATS/IDSA statement: Diagnosis, treatment and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175(4):367–416.
- Chen HH, Hsiao CH, Chiu HC. Successive development of cutaneous polyarteritis nodosa, leucocytoclastic vasculitis and Sweet’s syndrome in a patient with cervical lymphadenitis caused by Mycobacterium fortuitum. Br J Dermatol. 2004;151(5):1096–1100.
- Al Shaalan M, Law BJ, Israels SJ, Pianosi P, Lacson AG, Higgins R. Mycobacterium fortuitum interstitial pneumonia with vasculitis in a child with Wilms’ tumor. Pediatr Infect Dis J. 1997;16(10):996–1000.